跳至主要内容
临床试验/NCT03456037
NCT03456037Unknown不适用

Incidence Of Hepatitis And Its Effect On Prognosis In Patients Who Follow In Intensive Care Unit

Sakarya University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2018年4月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
1
主要终点
HBsAg

研究概览

简要总结

The aim is to investigate incidence of HBsAg, anti-HCV in serum samples and evaluation of biomarkers taken from patients who were followed the intensive care unit of Sakarya University Training and Research Hospital and The intensive care unit attracts attention by making health workers more susceptible to the risk of hepatitis.

详细描述

This retrospective study included 536 cases who were followed with various diagnoses in intensive care units between 1 Ocak 2015 ile 1 Ocak 2016, covering the six months period, retrospectively. Sakarya University's Faculty of Medicine Review Board (71522473/050.01.04/113) approved the study after approval of the research ethics committee (. Medical record forms and electronic medical record system of the hospital were used in the analysis of medical data with regard to age, sex, HBsAg, anti-HCV, AST, ALT, bilirubin, creatinine levels.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients who were followed in the intensive care unit

排除标准

  • 未提供

结局指标

主要结局

HBsAg

时间窗: 1 month

HBsAg is the serologic hallmark of HBV infection and is the first marker to appear after acute infection.

次要结局

  • anti-HCV(1mounth)

研究者

发起方
Sakarya University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Havva Sayhan

Assistant Professor

Sakarya University

研究点 (1)

Loading locations...

相似试验

Incidence Of Hepatitis In Intensive Care Unit | 临床试验